# US Gynecological Devices Instruments Market

> US Gynecological Devices and Instruments Market Research Report By Surgical Devices (Endoscopy, Endometrial Ablation, Others) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 7.78%
- **2024:** $ 1,798.29 Million
- **2025:** $ 1,938.2 Million
- **2035:** $ 4,100 Million
- **Key Players:** Medtronic (IE), Johnson & Johnson (US), Stryker (US), Boston Scientific (US), Hologic (US), B. Braun Melsungen AG (DE), CooperSurgical (US), Smith & Nephew (GB), Fujifilm Holdings Corporation (JP)

**Report ID:** MRFR/MED/16421-HCR · **Pages:** 100 · **Author:** Nidhi Mandole & Garvit Vyas · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-gynecological-devices-instruments-market-17949

---

## Market Summary

## **US Gynecological Devices and Instruments Market Overview**

As per MRFR analysis, the US Gynecological Devices and Instruments Market Size was estimated at 1.96 (USD Billion) in 2023. The US Gynecological Devices and Instruments Market Industry is expected to grow from 2.1(USD Billion) in 2024 to 3.5 (USD Billion) by 2035. The US Gynecological Devices and Instruments Market CAGR (growth rate) is expected to be around 4.753% during the forecast period (2025 - 2035).

### **Key US Gynecological Devices and Instruments Market Trends Highlighted**

The US [Gynecological Devices and Instruments Market](../../../reports/gynecological-devices-instruments-market-5990) is currently experiencing significant growth driven by a variety of factors. A key market driver is the increasing incidence of gynecological disorders such as polycystic ovary syndrome, endometriosis, and various cancers, which necessitate advanced diagnostic and treatment tools. Additionally, the rising awareness and focus on women's health have led to increased demand for gynecological care and interventions, encouraging innovation within the industry.

Alongside this, the growth of minimally invasive surgical techniques is promoting the use of sophisticated devices and instruments designed for enhanced patient comfort and recovery. Opportunities within the US market can be leveraged by focusing on the integration of advanced technologies, such as artificial intelligence and robotics, which can enhance surgical precision and outcomes. The aging population may also present a demographic opportunity, as this group tends to require increased medical attention, including gynecological care.

Furthermore, increasing preferences for preventive care and early diagnosis offer potential for growth, as women become more proactive about their health. Recent trends indicate a shift towards patient-centered care, with a growing emphasis on enhancing the overall patient experience during gynecological procedures. The adoption of telemedicine has surged, particularly in response to the COVID-19 pandemic, allowing for easier access to gynecological consultations and follow-ups.

Additionally, the push towards biodegradable and sustainable materials in the development of gynecological devices reflects a broader trend in environmental consciousness among healthcare providers and patients alike. This focus on sustainability, alongside technological innovation, is shaping the future landscape of the US Gynecological Devices and Instruments Market.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **US Gynecological Devices and Instruments Market Drivers**

#### **Rising Incidence of Gynecological Disorders**

The increasing prevalence of gynecological disorders is a significant driver for the US Gynecological Devices and Instruments Market industry. Studies from the Centers for Disease Control and Prevention indicate that over 15 million American women experience disorders such as endometriosis and fibroids each year. With an aging population and the rising awareness about women's health, more patients are seeking diagnosis and treatment, leading to an escalation in demand for specialized gynecological devices.

Major healthcare organizations, like the American College of Obstetricians and Gynecologists, are advocating for improved access to gynecological care, which would further increase the market for related devices and instruments. This push for enhanced patient care methodologies aligns with the growing need for advanced and specialized medical devices in hospitals and clinics.

#### **Technological Advancements in Medical Equipment**

Advancements in technology have contributed significantly to the growth of the US Gynecological Devices and Instruments Market industry. Innovations such as minimally invasive surgical techniques and enhanced imaging technologies have improved the efficacy of gynecological treatments. According to the Food and Drug Administration, more than 80% of new gynecological devices approved in recent years have incorporated advanced technology features.

Established companies such as Medtronic and Johnson & Johnson are implementing high-tech solutions that enhance surgical precision and patient safety. As these devices continue to evolve, they are likely to attract more healthcare providers, releasing additional pressures on existing services and expanding the market scope.

#### **Increased Government Support for Women's Health Initiatives**

Government engagement in women's health initiatives is a catalyst for growth in the US Gynecological Devices and Instruments Market industry. Legislative measures such as the Women's Health Equity Act promote research, development, and accessibility of gynecological health treatments. The National Institutes of Health has allocated significant funding for studies focused on gynecological diseases, totaling over 300 million USD annually.

This support facilitates innovation in device development, making sophisticated instruments more widely available in the healthcare sector. Additionally, public health campaigns aimed at educating women about gynecological health issues foster greater awareness, further propelling the demand for effective medical solutions in hospitals and clinics.

### **US Gynecological Devices and Instruments Market Segment Insights**

#### **Gynecological Devices and Instruments Market Surgical Devices Insights**

The Surgical Devices segment within the US Gynecological Devices and Instruments Market demonstrates substantial growth potential, driven by increasing demand for minimally invasive procedures and advancements in surgical technology. Endoscopy has emerged as a vital technique within this segment, allowing healthcare professionals to perform surgeries with enhanced precision and reduced recovery time, thereby improving patient outcomes significantly.

With the rise in the prevalence of gynecological disorders such as endometriosis and fibroids, the need for effective surgical interventions continues to grow, placing endoscopic procedures at the forefront of treatment options. Furthermore, Endometrial Ablation represents another critical aspect of this segment, offering a safe and efficient method for managing abnormal uterine bleeding. This technique, preferred for its ability to preserve fertility and reduce the need for more invasive surgeries, emphasizes the increasing trend toward patient-centric care in gynecological treatments.

The Others classification also plays a significant role, encompassing a variety of surgical devices tailored to meet the specific needs of gynecological surgeries, further enhancing the diversity of treatment options available to healthcare providers. The growing focus on women's health and the emphasis on innovative solutions that enhance the quality of care provide considerable opportunities for stakeholders in the US Gynecological Devices and Instruments Market.

Additionally, regulatory support and an increase in Research and Development activities are expected to drive advancements in this segment, enhancing the overall efficiency and safety of surgical devices. Market growth is also influenced by educational initiatives aimed at both healthcare professionals and patients, ensuring that emerging technologies are understood and effectively utilized in clinical settings.

Overall, the Surgical Devices segment is pivotal in transforming how gynecological procedures are performed, reflecting a broader trend within the healthcare industry aimed at improving patient access to cutting-edge medical solutions. As this segment evolves, it continues to pave the way for innovative therapeutics, yielding significant implications for female healthcare in the US.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **US Gynecological Devices and Instruments Market Key Players and Competitive Insights**

The US Gynecological Devices and Instruments Market is characterized by rapid advancements in technology and a growing emphasis on women's health. This sector is evolving through innovation in product offerings, encompassing diagnostic devices, surgical instruments, and minimally invasive techniques, which contribute to enhanced patient outcomes and safety. The competitive landscape is influenced by several factors, including regulatory changes, increasing incidence of gynecological disorders, and heightened awareness about women's health. These dynamics lead to a strong focus on research and development efforts, enabling companies to introduce cutting-edge solutions that cater to diverse healthcare needs and preferences.

Understanding the market's competitive insights is crucial for stakeholders looking to navigate this rapidly changing environment and capitalize on emerging opportunities.

Hologic stands out in the US Gynecological Devices and Instruments Market due to its comprehensive portfolio that focuses on women's health, specifically in areas such as breast health, cervical health, and surgical solutions. The company's strengths include a commitment to innovation and a robust research foundation that allows it to stay ahead of trends in gynecological care. Hologic has gained significant market presence through its advanced technologies and a strong sales force, ensuring effective distribution of its products in various healthcare settings.

Furthermore, Hologic's strategic partnerships and collaborations foster continuous improvement in product development and enhance its reputation among healthcare providers, facilitating widespread adoption of its devices and instruments in the US market.

Smith and Nephew has also established a prominent presence in the US Gynecological Devices and Instruments Market, primarily through its expertise in surgical devices, wound care, and advanced orthopedic solutions. The company is known for key products such as endoscopic instruments and minimally invasive surgical systems that are designed to improve patient recovery times and surgical efficiency. Smith and Nephew's strengths lie in its innovative research initiatives and a strong focus on quality and clinical efficacy, allowing it to deliver reliable products to healthcare practitioners.

The company has pursued strategic mergers and acquisitions to expand its product portfolio and bolster its market position, thereby enhancing its competitive edge. With a commitment to enhancing surgical outcomes and streamlined processes, Smith and Nephew continues to play a crucial role in shaping the evolving landscape of gynecological care in the US.

### **Key Companies in the US Gynecological Devices and Instruments Market Include**

### **US Gynecological Devices and Instruments Market Industry Developments**

Recent developments in the US Gynecological Devices and Instruments Market include advancements in minimally invasive surgical techniques, leading to an increased demand for innovative devices. Notably, Hologic has launched new products enhancing diagnostics and treatment options, aiming to improve patient outcomes. In terms of market dynamics, Boston Scientific and Medtronic have reported significant growth in sales, attributed to the rising prevalence of gynecological conditions and increased patient awareness.

Recent merger and acquisition activity includes Smith and Nephew acquiring a technology firm in September 2023 to expand its product portfolio, while Ethicon announced its partnership with a fertility startup in August 2023 to enhance offerings in reproductive health. Additionally, Fertility Nutraceuticals has experienced a surge in demand, reflected in its revenue growth over the past year. The market has seen notable changes over the last few years, with significant investments in Research and Development by companies like Johnson and Johnson and Stryker, further pushing innovation.

Overall, the US Gynecological Devices and Instruments Market remains robust, supported by strategic collaborations and evolving healthcare needs.

### **US Gynecological Devices and Instruments Market Segmentation Insights**

#### **Gynecological Devices and Instruments Market Surgical Devices Outlook**

## Market Drivers

### Government Initiatives and Funding

Government initiatives aimed at improving women's health are playing a crucial role in the expansion of the gynecological devices-instruments market. Various federal and state programs are providing funding for research and development in women's health technologies. For example, the National Institutes of Health (NIH) has allocated substantial resources to support studies focused on gynecological health. These initiatives not only foster innovation but also encourage collaboration between public and private sectors. As a result, manufacturers are likely to benefit from increased investment in the development of new devices and instruments, thereby enhancing the overall market landscape.

### Growing Focus on Patient-Centric Care

The gynecological devices market is witnessing a paradigm shift towards patient-centric care. Healthcare providers are increasingly prioritizing patient preferences and experiences in treatment decisions. This trend is reflected in the development of devices that are designed with user-friendly features and improved ergonomics. As patients become more involved in their healthcare choices, the demand for instruments that enhance comfort and accessibility is expected to grow. This focus on patient-centricity not only improves satisfaction but also encourages adherence to treatment plans. Consequently, manufacturers who can align their product offerings with this trend are likely to gain a competitive edge in the gynecological devices-instruments market.

### Rising Incidence of Gynecological Disorders

The prevalence of gynecological disorders, including endometriosis, fibroids, and cervical cancer, is contributing to the growth of the gynecological devices-instruments market. Recent statistics indicate that approximately 1 in 10 women in the US suffer from endometriosis, leading to increased demand for diagnostic and therapeutic devices. Furthermore, the rising incidence of cervical cancer has prompted healthcare providers to enhance screening and treatment options. As awareness of these conditions grows, so does the need for specialized instruments, such as hysteroscopes and colposcopes. This trend suggests a robust market potential for manufacturers who can provide effective solutions tailored to these specific health challenges.

### Technological Integration in Healthcare Systems

The integration of advanced technologies into healthcare systems is significantly impacting the gynecological devices-instruments market. The adoption of electronic health records (EHR) and telemedicine is facilitating better patient management and follow-up care. This technological evolution allows for more efficient data sharing and enhances the overall patient experience. As healthcare providers increasingly utilize these technologies, the demand for compatible gynecological instruments is likely to rise. For instance, devices that can seamlessly integrate with EHR systems are becoming essential. This trend indicates a shift towards a more interconnected healthcare environment, which could drive growth in the gynecological devices-instruments market.

### Increasing Demand for Minimally Invasive Procedures

The gynecological devices market is experiencing a notable shift towards minimally invasive procedures. This trend is driven by patient preferences for reduced recovery times and lower risks of complications. According to recent data, minimally invasive surgeries account for approximately 60% of all gynecological procedures in the US. As healthcare providers adopt advanced technologies, such as laparoscopic instruments and robotic-assisted systems, the demand for these devices is expected to rise. This shift not only enhances patient outcomes but also aligns with the broader trend of improving surgical efficiency. Consequently, manufacturers are focusing on developing innovative instruments that cater to this growing demand, thereby propelling the gynecological devices-instruments market forward.

## Future Outlook

The [Gynecological Devices Instruments Market](https://www.marketresearchfuture.com/reports/gynecological-devices-instruments-market-5990) is projected to grow at a 7.78% CAGR from 2025 to 2035, driven by technological advancements, increasing awareness, and rising healthcare expenditures.

**New opportunities:**

- Development of AI-driven diagnostic tools for early detection of gynecological conditions. Expansion of telehealth services for remote gynecological consultations. Introduction of biodegradable surgical instruments to enhance sustainability in healthcare.

By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare needs.

## Segment Insights

### By Type of Surgical Devices: Gynecological Endoscopy Devices (Largest) vs. Endometrial Ablation Devices (Fastest-Growing)

In the US gynecological devices-instruments market, the segment values are characterized by distinct share distributions. Gynecological Endoscopy Devices hold the largest market share, driven by their extensive application in minimally invasive procedures. In contrast, Endometrial Ablation Devices, though smaller in overall share, are quickly gaining traction due to increasing demand for non-invasive treatments. The presence of advanced technologies in endoscopy also contributes significantly to its dominant position in the market.

Growth trends indicate a robust increase in demand for minimally invasive surgical options as patients prefer quicker recovery times and reduced surgical risks. The Endometrial Ablation Devices segment is witnessing rapid expansion driven by rising awareness about women's health and advancements in technology, making these devices more effective and safer. Fluid Management Systems and Female Sterilization/Contraceptive Devices continue to evolve but at a more stable growth rate, reflecting changing healthcare practices and patient preferences.

Gynecological Endoscopy Devices (Dominant) vs. Endometrial Ablation Devices (Emerging)

Gynecological Endoscopy Devices are currently the dominant segment in the market, renowned for their precision and minimal invasiveness. These devices facilitate various procedures, allowing for enhanced visualization of the gynecological anatomy and leading to better surgical outcomes. Furthermore, ongoing advancements in imaging technology and the development of sophisticated instruments contribute to their widespread adoption in clinical settings. On the other hand, Endometrial Ablation Devices, while emerging in this market, are gaining popularity for their effectiveness in treating abnormal uterine bleeding with minimal downtime. This segment's appeal is further bolstered by increased patient awareness and the push for less invasive treatment options, positioning it as a key growth driver in the gynecological devices-instruments landscape.

### By Type of Surgical Instruments: Forceps (Largest) vs. Scissors (Fastest-Growing)

The market share distribution among various surgical instruments in the US gynecological devices-instruments market shows that forceps hold the largest share, reflecting their essential role in various procedures. Other instrumental components, such as scissors, trocars, and vaginal speculums, also contribute significantly, while instruments like uterine sounds and depressors occupy niche segments, catering to specific medical needs.

Growth trends for surgical instruments are being driven by advancements in technology and increasing demand for minimally invasive procedures. As hospitals and clinics focus on enhancing patient outcomes and reducing recovery times, the adoption of innovative tools like advanced scissors is on the rise. This shift is fueling competition and encouraging manufacturers to invest in new designs and materials, ensuring compliance with the latest medical standards.

Forceps (Dominant) vs. Scissors (Emerging)

Forceps are characterized by their versatility and integral role in multiple gynecological procedures, making them the dominant instrument in the US gynecological devices-instruments market. Their design allows for precision and control, which is crucial during surgeries. In contrast, scissors are emerging as a preferred choice due to their adaptability in various surgical scenarios. The increasing focus on patient safety and efficacy in procedures fosters a demand for high-quality scissors that can meet the evolving requirements of healthcare professionals. As innovations continue to reshape the landscape, both forceps and scissors will play pivotal roles in enhancing surgical outcomes.

### By Application: Laparoscopy (Largest) vs. Hysteroscopy (Fastest-Growing)

The US gynecological devices-instruments market is characterized by notable segment values, with laparoscopy commanding the largest market share. This segment is widely recognized for its minimally invasive surgical techniques, allowing for quicker patient recovery and lower complication rates. Hysteroscopy, while smaller in market share, is rapidly evolving, driven by increasing demand for outpatient procedures and advancements in technology.

The growth drivers within this segment include rising awareness about women's health, technological innovations, and a shift towards minimally invasive surgeries. As more healthcare providers adopt these technologies, the preference for procedures like hysteroscopy is expected to surge. This trend reflects a broader movement towards personalized and efficient healthcare solutions, further boosting the segment's overall growth prospects.

Laparoscopy (Dominant) vs. Hysteroscopy (Emerging)

Laparoscopy continues to dominate the US gynecological devices-instruments market, primarily due to its established benefits which include less postoperative pain and reduced scarring compared to traditional surgery. As an essential tool for various gynecological and gynecologic-oncologic procedures, it plays a critical role in minimally invasive surgeries. On the other hand, hysteroscopy is an emerging segment gaining traction, primarily employed for diagnosing and treating intrauterine pathologies. The ability to perform procedures in an outpatient setting is enhancing its appeal. Both segments illustrate the trend towards advanced gynecological care, with laparoscopy leading the way while hysteroscopy is poised for accelerated growth, driven by technological advancements and increased health awareness.

### By End-User: Hospitals and Clinics (Largest) vs. Ambulatory Surgery Centers (Fastest-Growing)

In the US gynecological devices-instruments market, Hospitals and Clinics hold the largest share among end-users, driven by high patient volume and comprehensive services offered. This segment benefits from significant investments in advanced medical technology, enabling a wide array of gynecological procedures and treatments that cater to diverse patient needs. On the other hand, Ambulatory Surgery Centers are witnessing rapid growth, primarily fueled by the rising preference for outpatient procedures, coupled with cost-effectiveness and convenience for patients seeking minimally invasive treatments.

The growth trend within this segment is driven by increasing awareness about women's health issues and the demand for specialized gynecological care. Research and Academic Institutes also play a crucial role, though they primarily focus on advancements and innovation rather than direct patient care. Continuous investments in research are leading to the development of cutting-edge technologies, ensuring that these institutions remain influential in shaping future market dynamics. The overall landscape is significantly evolving, reflecting the changing preferences and needs of end-users in the gynecological devices-instruments market.

Hospitals and Clinics (Dominant) vs. Ambulatory Surgery Centers (Emerging)

Hospitals and Clinics dominate the US gynecological devices-instruments market due to their extensive resources, offering a full spectrum of healthcare services. They are equipped with advanced facilities and a wide range of specialized gynecological instruments, allowing for comprehensive patient management, from diagnosis to treatment. Conversely, Ambulatory Surgery Centers are emerging as a pivotal player in this sector, providing outpatient care that is both efficient and less costly. Their rise is characterized by increasing patient preference for procedures that do not require overnight hospitalization, thus propelling innovation and investment in surgical technologies that cater to this demand. The competition between these segments illustrates a dynamic healthcare landscape focused on improving patient outcomes and experiences.

## Competitive Benchmarking

The gynecological devices-instruments market is characterized by a dynamic competitive landscape, driven by innovation, technological advancements, and an increasing focus on women's health. Key players such as Medtronic (IE), Johnson & Johnson (US), and Hologic (US) are at the forefront, each adopting distinct strategies to enhance their market presence. Medtronic (IE) emphasizes innovation through its advanced surgical technologies, while Johnson & Johnson (US) focuses on expanding its product portfolio via strategic acquisitions. Hologic (US) is particularly noted for its commitment to women's health diagnostics, which positions it favorably in a market that increasingly prioritizes personalized healthcare solutions. Collectively, these strategies contribute to a competitive environment that is both concentrated and moderately fragmented, with significant implications for market dynamics.In terms of business tactics, companies are increasingly localizing manufacturing to enhance supply chain efficiency and reduce costs. This approach not only mitigates risks associated with The gynecological devices-instruments market demands. The competitive structure of the market appears to be moderately fragmented, with several key players exerting substantial influence. This fragmentation is indicative of a landscape where innovation and strategic partnerships are essential for maintaining competitive advantage.
In October Medtronic (IE) announced the launch of a new minimally invasive surgical device aimed at improving patient outcomes in gynecological procedures. This strategic move underscores Medtronic's commitment to innovation and aligns with the growing demand for less invasive treatment options. The introduction of this device is likely to enhance Medtronic's market share and reinforce its position as a leader in surgical technologies.
In September Johnson & Johnson (US) completed the acquisition of a promising startup specializing in AI-driven diagnostic tools for gynecological health. This acquisition is strategically significant as it not only expands Johnson & Johnson's technological capabilities but also positions the company to leverage AI in enhancing diagnostic accuracy and patient care. The integration of AI into their product offerings may provide a competitive edge in a market increasingly driven by technological advancements.
In August Hologic (US) launched a new digital platform designed to streamline patient management and enhance the overall patient experience in gynecological care. This initiative reflects Hologic's focus on digital transformation and its commitment to improving healthcare delivery. By investing in digital solutions, Hologic is likely to strengthen its market position and respond effectively to the evolving needs of healthcare providers and patients alike.
As of November current competitive trends in the gynecological devices-instruments market are heavily influenced by digitalization, sustainability, and the integration of AI technologies. Strategic alliances among key players are shaping the landscape, fostering innovation and enhancing product offerings. Looking ahead, it appears that competitive differentiation will increasingly pivot from price-based strategies to a focus on innovation, technological advancements, and supply chain reliability. This shift suggests that companies that prioritize these elements will likely emerge as leaders in the evolving market.

## Recent News & Developments

Recent developments in the US Gynecological Devices and Instruments Market include advancements in minimally invasive surgical techniques, leading to an increased demand for innovative devices. Notably, Hologic has launched new products enhancing diagnostics and treatment options, aiming to improve patient outcomes. In terms of market dynamics, Boston Scientific and Medtronic have reported significant growth in sales, attributed to the rising prevalence of gynecological conditions and increased patient awareness.

Recent merger and acquisition activity includes Smith and Nephew acquiring a technology firm in September 2023 to expand its product portfolio, while Ethicon announced its partnership with a fertility startup in August 2023 to enhance offerings in reproductive health. Additionally, Fertility Nutraceuticals has experienced a surge in demand, reflected in its revenue growth over the past year. The market has seen notable changes over the last few years, with significant investments in Research and Development by companies like Johnson and Johnson and Stryker, further pushing innovation.

Overall, the US Gynecological Devices and Instruments Market remains robust, supported by strategic collaborations and evolving healthcare needs.

## Report Scope

| MARKET SIZE 2024 | 1798.29(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 1938.2(USD Million) |
| MARKET SIZE 2035 | 4100.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.78% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Medtronic (IE), Johnson & Johnson (US), Stryker (US), Boston Scientific (US), Hologic (US), B. Braun Melsungen AG (DE), CooperSurgical (US), Smith & Nephew (GB), Fujifilm Holdings Corporation (JP) |
| Segments Covered | Type of Surgical Devices, Type of Surgical Instruments, Application, End-User |
| Key Market Opportunities | Integration of advanced imaging technologies enhances diagnostic accuracy in the gynecological devices-instruments market. |
| Key Market Dynamics | Technological advancements and regulatory changes drive innovation in the gynecological devices-instruments market. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What was the overall market valuation of the US gynecological devices-instruments market in 2024?**
A: The overall market valuation was $1798.29 Million in 2024.

**Q: What is the projected market valuation for the US gynecological devices-instruments market by 2035?**
A: The projected valuation for 2035 is $4100.0 Million.

**Q: What is the expected CAGR for the US gynecological devices-instruments market during the forecast period 2025 - 2035?**
A: The expected CAGR during the forecast period 2025 - 2035 is 7.78%.

**Q: Which companies are considered key players in the US gynecological devices-instruments market?**
A: Key players include Medtronic, Johnson & Johnson, Stryker, Boston Scientific, Hologic, B. Braun Melsungen AG, CooperSurgical, Smith & Nephew, and Fujifilm Holdings Corporation.

**Q: What are the major segments of the US gynecological devices-instruments market?**
A: Major segments include Type of Surgical Devices, Type of Surgical Instruments, Application, and End-User.

**Q: What was the valuation range for gynecological endoscopy devices in 2024?**
A: The valuation range for gynecological endoscopy devices was $400.0 Million to $900.0 Million.

**Q: How much did the female sterilization/contraceptive devices segment generate in 2024?**
A: The female sterilization/contraceptive devices segment generated between $748.29 Million and $1700.0 Million in 2024.

**Q: What is the projected growth for ambulatory surgery centers in the US gynecological devices-instruments market?**
A: Ambulatory surgery centers are projected to grow from $539.79 Million to $1220.0 Million by 2035.

**Q: What is the valuation range for forceps in the US gynecological devices-instruments market?**
A: The valuation range for forceps is between $200.0 Million and $450.0 Million.

**Q: What applications are included in the US gynecological devices-instruments market?**
A: Applications include laparoscopy, hysteroscopy, dilation and curettage, colposcopy, cervical cryosurgery, endometrial ablation, and endometrial biopsy.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-gynecological-devices-instruments-market-17949*